Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting SK ion channels.
| Website | https://acesionpharma.com |
| Revenue | $1 million |
| Employees | 21 (13 on RocketReach) |
| Founded | 2011 |
| Address | 93 Pederstrupvej, Ballerup, Region Hovedstaden 02750, DK |
| Phone | +45 44 64 08 76 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Medical, Health Care, Pharmaceutical |
| Web Rank | 6 Million |
| Keywords | Atrial Fibrillation, Drug Development, Biotechnology, Drug Discovery, Pharmaceutical, Biopharma, Cardiovascular, Heart Disease, Therapeutics, Clinical Trials, Treatment, Research, Innovation, Health, Scientific, Medical, Healthcare |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Acesion Pharma employee's phone or email?
The Acesion Pharma annual revenue was $1 million in 2026.
Anders Holst is the CEO of Acesion Pharma.
13 people are employed at Acesion Pharma.
Acesion Pharma is based in Ballerup, Region Hovedstaden.
The NAICS codes for Acesion Pharma are [325, 3254, 32, 32541].
The SIC codes for Acesion Pharma are [2834, 28, 283].